Narendra Solanki sees limited IT growth, bets on rural and pharma plays

The pharma sector is gaining attention as a defensive play amidst broader market volatility and geopolitical tensions. Regulatory signals and product pipelines remain crucial for individual stock performance.

Look for opportunities in pharmaceutical stocks with strong product pipelines and favorable regulatory outcomes, maintaining a long bias with strict stop-losses.

For Indian markets, this story mainly matters for , , and the Information Technology, Pharmaceuticals, FMCG - Rural pocket. The current signal is mixed, so traders should look for follow-through in price, volume, and sector breadth instead of reacting to the headline alone.

Watch whether the next market session confirms the setup described here: Narendra Solanki sees limited IT growth, suggesting potential headwinds for the sector. Rural consumption shows resilience, making it an attractive investment area. Also track volume confirmation, sector participation, and whether the move holds beyond the first reaction.

• •Narendra Solanki sees limited IT growth.
• •He bets on rural and pharma plays.
• •Investors are becoming selective, focusing on earnings visibility and strong balance sheets.
• •Rural consumption shows resilience, while urban demand is mixed.
• •Infrastructure may see future gains from Middle East reconstruction.